Clinical trials
Completed Essential Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2006 | 3 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2019 | 1 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd. | 4 |
| Daiichi Sankyo | 2 |
| Shanghai Pharmaceuticals Holding Co., Ltd | 2 |
| Takeda | 2 |
| Anhui Medical University | 1 |
| Bayer | 1 |
| Capital Medical University | 1 |
| Chengdu University of Traditional Chinese Medicine | 1 |
| China Academy of Chinese Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 31 |
| Hypertension | 9 |
| Adrenocortical Adenoma | 1 |
| Atrial Fibrillation | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Familial Primary Pulmonary Hypertension | 1 |
| Hyperaldosteronism | 1 |
| Hyperuricemia | 1 |
| Lower Urinary Tract Symptoms | 1 |
| Prehypertension | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.